Asthma

This treatment approach helps reduce symptoms and future exacerbations triggered by dust mites, pet dander, pollen.

Balancing clinicians’ priorities with the needs of patients and their families is crucial to ensure access and adherence to medications.

Teach pharmacy staff members to know and address the roadblocks, keep up with changing guidelines.

But analysis does suggest a small increase in risk for individuals who used cigarettes and electronic nicotine delivery systems together.

Data show that dose-response relationships and long-term safety of ICS in people with chronic obstructive pulmonary disease are unclear and require further investigation.

The new findings, which include updated data, contradict results of a previous analysis by the same investigators.

Data show pharmacist-led clinical consultations can improve patient adherence to medication plans.

In a clinical trial program, 92% of health care providers, patients, and caregivers were able to successfully administer tezepelumab-ekko both in the clinic and at home for severe asthma.

The drug combination can significantly improve lung function and reduce severe asthma exacerbations.

FDA committee voted that trial data do not support the benefits outweighing the risks in patients aged 12 to 17 years and children aged 4 to 11 years for the use of albuterol/budesonide in the treatment of asthma.

Inhibiting the calcium release-activated calcium channel found to be an effective approach to limit allergic asthma without affecting the body’s defenses against influenza.

Dupilumab is used as a maintenance therapy when added to other asthma medications.

Aobbiy is a lung expansion and mucus relief device that aids in mucus removal to help clear the airway.

FDA approved dexamethasone tablets USP 1.5mg, 4mg and 6mg, providing a new generic alternative to the steroid Decadron.

Subcutaneous immunotherapy-induced antibodies may serve as a potential allergen-targeted biologics candidate for the treatment of allergic asthma.

ProAir Digihaler Inhalation Powder is indicated for the treatment or prevention of bronchospasm in those with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.

Study findings provide evidence that preventative antibiotics improve health outcomes for babies and mothers, investigator say.

The study marks the first time an albuterol/budesonide fixed-dose combination rescue medication has reduced severe exacerbations, the company said.

The combination of albuterol/budesonide shows promise in lowering the risk of severe exacerbations and improved lung function compared to albuterol as a rescue inhaler in patients with asthma.

Second analysis indicates that parents of children with food allergies became less anxious during the pandemic.

National Asthma and Allergy Awareness Month highlights how pharmacists in all health care settings are in a unique position to improve management and outcomes of individuals with these conditions.

This month's OTC case studies focuses on asthma.

Asthma contributed most to the risk of high blood pressure and coronary heart disease.

Asmanex HFA is a corticosteroid indicated for the maintenance treatment of asthma as prophylactic therapy in patients 12 years of age and older

Singulair is a leukotriene receptor antagonist indicated for prophylaxis and chronic treatment of asthma.

Agency hopes green light for complex drug device combination improves competition and access more affordable medications.

Nucala is an IL-5 antagonist monoclonal antibody (immunoglobulin G1 kappa) for the add-on maintenance treatment of adult and pediatric patients with severe asthma and with an eosinophilic phenotype.

Study findings support the role of tezepelumab-ekko as a first-in-class treatment for a broad population of patients living with severe asthma, irrespective of biomarker levels.

Wixela Inhub is indicated for the treatment of asthma in patients 4 years of age and older and maintenance treatment of patients with chronic obstructive pulmonary disease.

Breo Ellipta is indicated for long-term, once-daily, maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease.